Cartio Therapeutics is a biotech startup focusing on the development of cellular immunotherapies for cardiovascular disease. They focus on the use of genetically modified T-cells (CAR T-cells) to treat atherosclerotic heart disease.
In the creation of the logo, we aimed to capture the key traits of the company's immunotherapy. In this case, we highlighted both the use of T-cells and the cyclical nature of the immunotherapy through the emphasis on the "T" and the oval graphic. We also slanted the text to emphasize the innovative nature of the company.